title: [Montelukast induced cytolytic acute hepatitis].
authors.forename: Jacques
authors.initials: J
authors.lastname: Margery
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Dot
authors.forename: Christian
authors.initials: C
authors.lastname: Bredin
authors.forename: Augustin
authors.initials: A
authors.lastname: Bonnichon
authors.forename: François
authors.initials: F
authors.lastname: Romand
authors.forename: Joël
authors.initials: J
authors.lastname: Guigay
authors.forename: Fabien
authors.initials: F
authors.lastname: Vaylet
authors.forename: Pierre
authors.initials: P
authors.lastname: L'Her
mesh_terms: D000085:Acetates / Q000009:adverse effects*; D000208:Acute Disease; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D003521:Cyclopropanes; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D020024:Leukotriene Antagonists / Q000009:adverse effects*; D011804:Quinolines / Q000009:adverse effects*; D013440:Sulfides; D013997:Time Factors
chemical_list: D000085:Acetates; D018927:Anti-Asthmatic Agents; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast